Hsbc Holdings PLC Makes New $30.68 Million Investment in The Cooper Companies, Inc. $COO

Hsbc Holdings PLC bought a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 428,065 shares of the medical device company’s stock, valued at approximately $30,678,000.

Several other hedge funds and other institutional investors have also made changes to their positions in COO. BlackRock Inc. purchased a new position in Cooper Companies during the second quarter worth about $1,077,762,000. Generation Investment Management LLP purchased a new stake in Cooper Companies in the 2nd quarter valued at approximately $356,304,000. Wellington Management Group LLP increased its position in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares during the period. Diamond Hill Capital Management Inc. increased its position in Cooper Companies by 479.6% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after purchasing an additional 2,720,594 shares during the period. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after buying an additional 2,231,568 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

COO stock opened at $70.96 on Friday. The firm has a 50 day moving average of $72.46 and a 200-day moving average of $70.88. The company has a market cap of $13.84 billion, a price-to-earnings ratio of 60.14, a PEG ratio of 1.90 and a beta of 0.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the prior year, the firm posted $0.96 EPS. The company’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on COO shares. Citigroup reissued a “neutral” rating and issued a $80.00 price target (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. JPMorgan Chase & Co. cut their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Finally, UBS Group assumed coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $81.64.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.